AJP - Endo Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Am J Physiol Endocrinol Metab 257: E439-E443, 1989;
0193-1849/89 $5.00
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ostenson, C. G.
Right arrow Articles by Efendic, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ostenson, C. G.
Right arrow Articles by Efendic, S.

AJP - Endocrinology and Metabolism, Vol 257, Issue 3 E439-E443, Copyright © 1989 by American Physiological Society

ARTICLES

Alpha-adrenoceptors and insulin release from pancreatic islets of normal and diabetic rats

C. G. Ostenson, A. G. Cattaneo, J. C. Doxey and S. Efendic
Department of Endocrinology, Karolinska Hospital, Stockholm, Sweden.

The role of alpha-adrenoceptors in the regulation of glucose-induced insulin release (GIR) was investigated in islets of normal and neonatally streptozotocin-injected non-insulin-dependent diabetic rats (STZ). In normal islets GIR was suppressed to approximately 50% by 10(-8) M of the alpha 2-adrenergic agonist UK 14304, whereas 10(-9) M of the agonist induced a similar inhibition in STZ islets. In normal islets, suppression of GIR by UK 14304 (10(-8) M) was totally antagonized by 10(6) M idazoxan (alpha 2-antagonist) or 10(6) M phentolamine (alpha 1 + alpha 2-antagonist). In STZ islets, the inhibitory effect of UK 14304 (10(-9) M) was entirely reversed by 10(-5) M idazoxan or 10(-6) M phentolamine. The alpha 1-antagonist prazosin (10(-7)-10(-5) M) was without effect on insulin release suppressed by UK 14304 in normal and STZ islets. Insulin release at 3.3, 8.3, or 16.7 mM glucose was augmented by phentolamine but not by idazoxan. It is concluded that the inhibitory effect of catecholamines on insulin release is mediated by alpha 2-receptors in normal and STZ islets. Phentolamine augments basal and glucose-induced insulin release by a mechanism that does not involve alpha 2-adrenoceptors.


This article has been cited by other articles:


Home page
 DiabetesHome page
S. Efendic, A. M. Efanov, P.-O. Berggren, and S. V. Zaitsev
Two Generations of Insulinotropic Imidazoline Compounds
Diabetes, December 1, 2002; 51(90003): S448 - 454.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
A. M. Efanov, S. V. Zaitsev, I. B. Efanova, S. Zhu, C.-G. Ostenson, and P.-O. Berggren
Signaling and sites of interaction for RX-871024 and sulfonylurea in the stimulation of insulin release
Am J Physiol Endocrinol Metab, April 1, 1998; 274(4): E751 - E757.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online